Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

View source ↗

Summary

This clinical trial update describes the Li-Fraumeni & TP53 (LiFT UP) study focused on understanding TP53-related Li-Fraumeni syndrome and hereditary cancer pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Li-Fraumeni Syndrome, TP53 Gene Mutation | Status: RECRUITING